177 related articles for article (PubMed ID: 18066593)
1. Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.
Subramaniam MM; Lazar N; Navarro S; Perbal B; Llombart-Bosch A
Virchows Arch; 2008 Jan; 452(1):33-9. PubMed ID: 18066593
[TBL] [Abstract][Full Text] [Related]
2. novH: differential expression in developing kidney and Wilm's tumors.
Chevalier G; Yeger H; Martinerie C; Laurent M; Alami J; Schofield PN; Perbal B
Am J Pathol; 1998 Jun; 152(6):1563-75. PubMed ID: 9626060
[TBL] [Abstract][Full Text] [Related]
3. CITED1 expression in Wilms' tumor and embryonic kidney.
Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M
Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162
[TBL] [Abstract][Full Text] [Related]
4. Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.
Li MH; Sanchez T; Pappalardo A; Lynch KR; Hla T; Ferrer F
Mol Cancer Res; 2008 Oct; 6(10):1649-56. PubMed ID: 18922980
[TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
Natrajan R; Little SE; Reis-Filho JS; Hing L; Messahel B; Grundy PE; Dome JS; Schneider T; Vujanic GM; Pritchard-Jones K; Jones C
Clin Cancer Res; 2006 Dec; 12(24):7284-93. PubMed ID: 17189400
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression of SALL4 in Wilms tumors and developing kidney.
Deisch J; Raisanen J; Rakheja D
Pathol Oncol Res; 2011 Sep; 17(3):639-44. PubMed ID: 21258884
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
8. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.
Planque N; Long Li C; Saule S; Bleau AM; Perbal B
J Cell Biochem; 2006 Sep; 99(1):105-16. PubMed ID: 16598765
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a monoclonal antibody recognizing the blastemal element of Wilms' tumors and fetal kidneys.
Tarnowski BI; Hazen-Martin DJ; Garvin AJ; Sens MA; Sens DA
Pediatr Pathol; 1994; 14(5):849-62. PubMed ID: 7808983
[TBL] [Abstract][Full Text] [Related]
10. Cell differentiation in Wilms' tumor (nephroblastoma): an immunohistochemical study.
Droz D; Rousseau-Merck MF; Jaubert F; Diebold N; Nezelof C; Adafer E; Mouly H
Hum Pathol; 1990 May; 21(5):536-44. PubMed ID: 1692563
[TBL] [Abstract][Full Text] [Related]
11. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.
Natrajan R; Reis-Filho JS; Little SE; Messahel B; Brundler MA; Dome JS; Grundy PE; Vujanic GM; Pritchard-Jones K; Jones C
Cancer Res; 2006 Dec; 66(23):11148-55. PubMed ID: 17145858
[TBL] [Abstract][Full Text] [Related]
12. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
14. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
[TBL] [Abstract][Full Text] [Related]
15. Detection of truncated midkine in Wilms' tumor by a monoclonal antibody against human recombinant truncated midkine.
Paul S; Mitsumoto T; Asano Y; Kato S; Kato M; Shinozawa T
Cancer Lett; 2001 Feb; 163(2):245-51. PubMed ID: 11165761
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a monoclonal antibody recognizing selective epithelial elements of Wilms' tumors and fetal kidneys.
Tarnowski BI; Sens MA; Garvin AJ; Hazen-Martin DJ; Sens DA
Pediatr Pathol; 1994; 14(5):833-47. PubMed ID: 7808982
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor.
Karth J; Ferrer FA; Perlman E; Hanrahan C; Simons JW; Gearhart JP; Rodriguez R
J Pediatr Surg; 2000 Dec; 35(12):1749-53. PubMed ID: 11101729
[TBL] [Abstract][Full Text] [Related]
18. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.
Bleau AM; Planque N; Lazar N; Zambelli D; Ori A; Quan T; Fisher G; Scotlandi K; Perbal B
J Cell Biochem; 2007 Aug; 101(6):1475-91. PubMed ID: 17340618
[TBL] [Abstract][Full Text] [Related]
20. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
